Hypotensive response to angiotensin II analogue in benign essential hypertension.

Angiotensin II in essential hypertension.

[A reduced aldosterone response to infused angiotensin II in low renin essential hypertension (author's transl)].

Decreased mesenteric vascular response to angiotensin II in portal hypertension.

Role of renin-angiotensin system in experimental hypertension in rats: plasma renin and hypotensive effect of angiotensin II antagonist.

Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.

Hypotensive Response to Angiotensin II Type 2 Receptor Stimulation in the Rostral Ventrolateral Medulla Requires Functional GABA-A Receptors.

Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II.

Coronary haemodynamic effects of angiotensin II in mild essential hypertension in man.

Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.

Dissociation of blood angiotensin II and plasma renin activity during chronic treatment in essential hypertension.

The adrenal receptor for angiotensin II is altered in essential hypertension.

Hypotensive response to angiotensin I-converting enzyme inhibitor in Bartter's syndrome.

Increased plasma adrenaline concentrations in benign essential hypertension.

Renal injury from angiotensin II-mediated hypertension.

Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: the effect of treatment with an angiotensin II receptor blocker.

Response to mental and physical stress before and during adrenoreceptor blocker and angiotensin-converting enzyme inhibitor treatment in essential hypertension.

Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.

Magnesium pyrrolidone carboxylate infusion reduces angiotensin II pressor response in pregnant women at risk for hypertension.

Treatment of benign essential hypertension: comparison of furosemide and hydrochlorothiazide.

Effects of aging and hypertension on plasma angiotensin II and platelet angiotensin II receptor density.

Twenty-four hour profile of the hypotensive action of felodipine in essential hypertension.

Essential Hypertension: Cardiovascular Response to Breath Hold Combined with Exercise.

Hypotensive activity of TCV-116, a newly developed angiotensin II receptor antagonist, in spontaneously hypertensive rats.

Role of cyclic AMP and angiotensin III in the response of toad skin to angiotensin II.

Suggest Documents

Angiotensin II in essential hypertension.

[A reduced aldosterone response to infused angiotensin II in low renin essential hypertension (author's transl)].

Decreased mesenteric vascular response to angiotensin II in portal hypertension.

Role of renin-angiotensin system in experimental hypertension in rats: plasma renin and hypotensive effect of angiotensin II antagonist.

Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.

Hypotensive Response to Angiotensin II Type 2 Receptor Stimulation in the Rostral Ventrolateral Medulla Requires Functional GABA-A Receptors.

Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II.

Coronary haemodynamic effects of angiotensin II in mild essential hypertension in man.

Abnormal adrenal responsiveness and angiotensin II dependency in high renin essential hypertension.

Dissociation of blood angiotensin II and plasma renin activity during chronic treatment in essential hypertension.

The adrenal receptor for angiotensin II is altered in essential hypertension.

Hypotensive response to angiotensin I-converting enzyme inhibitor in Bartter's syndrome.

Increased plasma adrenaline concentrations in benign essential hypertension.

Renal injury from angiotensin II-mediated hypertension.

Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: the effect of treatment with an angiotensin II receptor blocker.

Response to mental and physical stress before and during adrenoreceptor blocker and angiotensin-converting enzyme inhibitor treatment in essential hypertension.

Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.

Magnesium pyrrolidone carboxylate infusion reduces angiotensin II pressor response in pregnant women at risk for hypertension.

Treatment of benign essential hypertension: comparison of furosemide and hydrochlorothiazide.

Effects of aging and hypertension on plasma angiotensin II and platelet angiotensin II receptor density.

Twenty-four hour profile of the hypotensive action of felodipine in essential hypertension.

Essential Hypertension: Cardiovascular Response to Breath Hold Combined with Exercise.

Hypotensive activity of TCV-116, a newly developed angiotensin II receptor antagonist, in spontaneously hypertensive rats.

Role of cyclic AMP and angiotensin III in the response of toad skin to angiotensin II.

Hypotensive response to angiotensin II analogue in benign essential hypertension.

Recommend Documents

Follow Us